FDA Inspection 1217174 — Strive Pharmacy Texas LLC
The FDA completed an inspection of Strive Pharmacy Texas LLC on Sep 8, 2023 in Boerne, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boerne, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22741 | FDCA 501(a)(2)(A) | Personnel exposure during aseptic manipulations |
| 22751 | FDCA 501(a)(2)(A) | Facility design, influx of lesser quality air |
| 22760 | FDCA 501(a)(2)(A) | Failure to clean and disinfect/sterilize equipment, ISO 5 area |